Engineered Cas9 variants bypass Keap1-mediated degradation in human cells and enhance epigenome editing efficiency is a research paper published in Nucleic Acids Research (2024). On theSindex it has a DataRank of 0. It has been cited 9 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH
Grant: R21CA270967
NIH
Grant: R01AR069085
NIH
Grant: U01AI146356
NIH
Grant: U01EB028901
UNC University Cancer Research Fund
Grant: R35GM148365
NIGMS NIH HHS
Grant: T32 GM148376
NCI NIH HHS
Grant: R01 CA097096
NIGMS NIH HHS
Grant: R01 GM132299
National Institutes of Health
Grant: 1U01AI146356-01
Epigenome Editing Technologies for Treating Diverse Disease
National Institutes of Health
Grant: 5R35GM148365-02
ILLUMINATION OF CHROMATIN REGULATION VIA CHEMICAL CONTROLLED PROXIMITY
National Institutes of Health
Grant: 1R21CA270967-01
Cancer Hijacks Enzyme Substrate Mutations to Facilitate Tumorigenesis
National Institutes of Health
Grant: 1U01EB028901-01
Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes
National Institutes of Health
Grant: 5R01AR069085-04
CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy
UNC Lineberger Comprehensive Cancer Center Development Award
Andrew McDonough B + Foundation Childhood Cancer Research
Pfizer-NCBiotech Distinguished Postdoctoral Fellowship
Pfizer-NCBiotech Distinguished Postdoctoral Fellowship
UNC Lineberger Comprehensive Cancer Center Development Award
Andrew McDonough B + Foundation Childhood Cancer Research
FWCI
1.47
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords